Peptides for Diabetic Wound Healing
Medically reviewed by Dr. Sarah Chen, PharmD, BCPS
> # Peptides for Diabetic Wound Healing: A Promising Therapeutic Strategy > > Diabetic wounds, particularly foot ulcers, are a major complication of diabetes and a leading cause of non-traumatic...
> # Peptides for Diabetic Wound Healing: A Promising Therapeutic Strategy
>
> Diabetic wounds, particularly foot ulcers, are a major complication of diabetes and a leading cause of non-traumatic lower limb amputations. The healing of these wounds is often impaired due to a combination of factors, including poor circulation, nerve damage, and a dysregulated inflammatory response. In recent years, there has been a growing interest in the use of peptides to promote the healing of diabetic wounds. Peptides are short chains of amino acids that can act as signaling molecules, modulating various aspects of the wound healing process, such as inflammation, angiogenesis, and cell proliferation. This article will provide an overview of the role of peptides in diabetic wound healing and highlight some of the most promising peptide-based therapies in this field.
>
> ## The Role of Peptides in Diabetic Wound Healing
>
> The wound healing process in diabetic patients is often stalled in the inflammatory phase, leading to a chronic, non-healing wound. Peptides can help to overcome this by modulating the inflammatory response and promoting a more favorable healing environment. For example, antimicrobial peptides (AMPs) are a class of peptides that have been shown to have potent antimicrobial activity against a wide range of pathogens, including those that are commonly found in diabetic wounds. [1] In addition, some AMPs have also been shown to have anti-inflammatory properties, which can help to reduce the excessive inflammation that is associated with diabetic wounds. [2]
>
> In addition to their antimicrobial and anti-inflammatory properties, peptides can also promote wound healing by stimulating angiogenesis, the formation of new blood vessels. Angiogenesis is essential for the delivery of oxygen and nutrients to the wound site, and it is a critical step in the healing process. Several peptides, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), have been shown to promote angiogenesis and accelerate diabetic wound healing. [3]
>
> ## Promising Peptide-Based Therapies for Diabetic Wound Healing
>
> Several peptide-based therapies are currently under investigation for the treatment of diabetic wounds, with some showing promising results in preclinical and clinical studies. One such therapy is the use of the peptide RL-QN15, which has been shown to promote wound healing of diabetic foot ulcers in a preclinical model. [4] Another promising peptide is QHREDGS, which has been shown to protect human epithelial cells from oxidative stress and promote cell migration and survival. [5]
>
> In addition to these, there are a number of other peptides that are being investigated for their diabetic wound healing properties. These include GHK-Cu, a copper-binding peptide that has been shown to have a wide range of regenerative and protective actions, including stimulating wound healing and reducing scar formation. [6] BPC-157 is another peptide that has been shown to accelerate wound healing and promote tissue regeneration. [7]
>
> | Peptide | Mechanism of Action | Potential Benefits in Diabetic Wound Healing |
> |---|---|---|
> | RL-QN15 | Promotes cell migration and proliferation | Accelerates wound healing of diabetic foot ulcers |
> | QHREDGS | Protects cells from oxidative stress, promotes cell migration | Enhances re-epithelialization and granulation tissue formation |
> | GHK-Cu | Stimulates collagen synthesis, anti-inflammatory | Promotes wound healing and reduces scar formation |
> | BPC-157 | Promotes angiogenesis and tissue regeneration | Accelerates wound healing |
>
> ## Future Directions and Challenges
>
> While peptide-based therapies hold great promise for the treatment of diabetic wounds, there are several challenges that need to be addressed. One of the main challenges is the delivery of peptides to the wound site. Peptides are often unstable and are quickly degraded in the body. To overcome this challenge, researchers are developing novel delivery systems, such as hydrogels and nanoparticles, to protect the peptides and deliver them to the wound site in a sustained manner. [8]
>
> Another challenge is the potential for immunogenicity. Some peptides can trigger an immune response, which could limit their effectiveness and cause side effects. To address this issue, researchers are designing peptides that are less likely to be recognized by the immune system. Despite these challenges, the field of peptide-based therapies for diabetic wound healing is rapidly advancing, and it is hoped that these therapies will one day provide a cure for this debilitating condition.
>
> ## Key Takeaways
>
> Peptide-based therapies are a promising new frontier in the treatment of diabetic wounds.
> Several peptides, such as RL-QN15 and QHREDGS, have shown promising results in preclinical and clinical studies.
> Peptide-based therapies offer the potential to not only accelerate wound healing but also to reduce the risk of complications, such as infection and amputation.
> Challenges in peptide delivery and immunogenicity need to be addressed to translate these promising therapies into clinical practice.
> The future of peptide-based therapies for diabetic wound healing is bright, with the potential to revolutionize the treatment of this debilitating condition.
> Patients with diabetic wounds should consult with their healthcare provider to discuss the latest treatment options.
> This article is for informational purposes only and should not be considered medical advice.
>
> > Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy or making changes to your health regimen.
>
> ### References
>
> [1] Gomes, A., Teixeira, C., Ferraz, R., Prudêncio, C., & Gomes, P. (2017). Wound-healing peptides for treatment of chronic diabetic foot ulcers and other infected skin injuries. Molecules (Basel, Switzerland), 22(10), 1743. https://pmc.ncbi.nlm.nih.gov/articles/PMC6151519/
>
> [2] Aquib, M., & Khan, A. (2025). Peptides in chronic wound healing: Fighting infections and promoting tissue regeneration in diabetic patients. Bioactive Materials, 34, 1-14. https://www.sciencedirect.com/science/article/pii/S1773224725000024
>
> [3] Van Slyke, P., Alami, J., & Martin, D. (2009). Acceleration of diabetic wound healing by an angiopoietin peptide mimetic. Tissue engineering. Part A, 15(6), 1287–1298. https://pubmed.ncbi.nlm.nih.gov/18991510/
>
> [4] Sun, D., & Chen, J. (2023). Peptide RL-QN15 promotes wound healing of diabetic foot ulcers by activating the Wnt/β-catenin signaling pathway. Burns & trauma, 11, tkad035. https://academic.oup.com/burnstrauma/article/doi/10.1093/burnst/tkad035/7423908
>
> [5] Xiao, Y., & Cai, J. (2016). Diabetic wound regeneration using peptide-modified hydrogels. Proceedings of the National Academy of Sciences of the United States of America, 113(44), E6666–E6675. https://www.pnas.org/doi/10.1073/pnas.1612277113
>
> [6] Cong, R., & Chen, H. (2025). Dimeric copper peptide incorporated hydrogel for promoting diabetic wound healing. Nature communications, 16(1), 1-15. https://www.nature.com/articles/s41467-025-61141-1
>
> [7] Seiwerth, S., Brcic, L., & Sikiric, P. (2018). BPC 157 and the gastrointestinal tract. Current pharmaceutical design, 24(18), 1990–2001. https://pubmed.ncbi.nlm.nih.gov/29998800/
>
> [8] Jeong, S. H., Cheong, S., & Kim, T. Y. (2023). Supramolecular hydrogels for precisely controlled antimicrobial peptide delivery for diabetic wound healing. ACS applied materials & interfaces, 15*(8), 10017–10029. https://pubs.acs.org/doi/abs/10.1021/acsami.3c00191
---